In pancreatic cancer, ANXA2 is highly expressed, acts as a tPA receptor to activate plasminogen, and consequently increases the invasiveness of pancreatic cancer cells by altering the extracellular matrix [101]. Here, PLG is linked to pancreatic neoplasm.